[go: up one dir, main page]

PE20080427A1 - Agentes antivirales - Google Patents

Agentes antivirales

Info

Publication number
PE20080427A1
PE20080427A1 PE2007000902A PE2007000902A PE20080427A1 PE 20080427 A1 PE20080427 A1 PE 20080427A1 PE 2007000902 A PE2007000902 A PE 2007000902A PE 2007000902 A PE2007000902 A PE 2007000902A PE 20080427 A1 PE20080427 A1 PE 20080427A1
Authority
PE
Peru
Prior art keywords
carboxi
quinolin
pyrrol
thiazol
dimethyl
Prior art date
Application number
PE2007000902A
Other languages
English (en)
Inventor
Franz Ulrich Schmitz
Christopher Don Roberts
Ronald Conrad Griffith
Janos Botyanszki
Son Mihn Pham
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of PE20080427A1 publication Critical patent/PE20080427A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE Y ES ARILO, HETEROARILO, HETEROARILO SUSTITUIDO, ENTRE OTROS; HET ES ARILENO DE 6 MIEMBROS, UN HETEROARILENO DE 6 MIEMBROS QUE CONTIENE 1, 2 o 3 HETEROATOMOS SELECCIONADOS ENTRE N, O, S Y UN ANILLO BICICLICO DE FORMULAS II, III, ENTRE OTROS; W1, W4 Y W5 SON CADA UNO N, CH; W3 ES N, CH, UNA UNION CON LA SALVEDAD DE QUE NO MAS QUE UN NITROGENO EN EL ANILLO BICICLICO SE OXIDA OPCIONALMENTE PARA FORMAR N-OXIDO; LA LINEA PUNTEADA ES UN ENLACE DOBLE O SIMPLE; UNO DE D o E C-Ra, Y EL OTRO DE D o E ES S; Ra Y R SON CADA UNO H, ALQUILO, ALQUILO SUSTITUIDO; Q ES CICLOALQUILO SUSTITUIDO O NO, CICLOALQUENILO, HETEROCICLO, ENTRE OTROS; Z ES CARBOXI, CARBOXI ESTER, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: ACIDO 6-CICLOPENTIL-5-[2-(2,4-DIMETIL-TIAZOL-5-IL)-QUINOLIN-6-IL]-4-(2-MORFOLIN-4-IL-2-OXO-ETIL)-4H-TIENO[3,2-b]PIRROL-2-CARBOXILICO; ACIDO {6-CICLOHEXIL-5-[2-(2,4-DIMETIL-TIAZOL-5-IL)-QUINOLIN-6-IL]-2-METANSULFONILAMINOCARBONIL-TIENO[3,2-b]PIRROL-4-IL}-ACETICO; ENTRE OTROS. DICHO COMPUESTO ES UTIL EN EL TRATAMIENTO DE HEPATITIS C MEDIADA POR EL VIRUS FLAVIVIRIDAE
PE2007000902A 2006-07-14 2007-07-13 Agentes antivirales PE20080427A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14

Publications (1)

Publication Number Publication Date
PE20080427A1 true PE20080427A1 (es) 2008-06-11

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000902A PE20080427A1 (es) 2006-07-14 2007-07-13 Agentes antivirales

Country Status (13)

Country Link
EP (1) EP2044083A1 (es)
JP (1) JP2009543807A (es)
KR (1) KR20090033881A (es)
CN (1) CN101490058A (es)
AR (1) AR062258A1 (es)
AU (1) AU2007272441A1 (es)
BR (1) BRPI0714346A2 (es)
CA (1) CA2657651A1 (es)
MX (1) MX2009000513A (es)
PE (1) PE20080427A1 (es)
RU (1) RU2009105196A (es)
TW (1) TW200813070A (es)
WO (2) WO2008008907A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
EP2494991A1 (en) 2007-05-04 2012-09-05 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of HCV infection
CA2784748A1 (en) 2009-12-18 2011-06-23 Idenix Pharmaceuticals, Inc. 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
EP2655362A1 (en) * 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) * 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
WO2016118043A1 (ru) 2015-01-20 2016-07-28 Виктор Вениаминович ТЕЦ Гемостатическое средство
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
EP3630082A4 (en) 2017-05-24 2021-12-15 Viktor Veniaminovich Tets FRACTIONED ANTIMICROBIAL COMPOSITIONS AND THEIR USE
US11661431B2 (en) 2021-04-16 2023-05-30 Gilead Sciences, Inc. Thienopyrrole compounds
CN117957234A (zh) 2021-09-10 2024-04-30 吉利德科学公司 噻吩并吡咯化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL395097A1 (pl) * 2001-06-11 2011-10-10 Vertex Pharmaceuticals (Canada) Incorporated Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu
RU2375350C2 (ru) * 2003-06-04 2009-12-10 Смитклайн Бичам Корпорейшн Азотсодержащие производные гетероарила

Also Published As

Publication number Publication date
AU2007272441A2 (en) 2009-03-19
CA2657651A1 (en) 2008-01-17
BRPI0714346A2 (pt) 2013-03-19
AU2007272441A1 (en) 2008-01-17
AR062258A1 (es) 2008-10-29
MX2009000513A (es) 2009-03-09
KR20090033881A (ko) 2009-04-06
EP2044083A1 (en) 2009-04-08
RU2009105196A (ru) 2010-08-27
TW200813070A (en) 2008-03-16
WO2008008912A1 (en) 2008-01-17
WO2008008907A2 (en) 2008-01-17
JP2009543807A (ja) 2009-12-10
CN101490058A (zh) 2009-07-22
WO2008008907A3 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
PE20080427A1 (es) Agentes antivirales
PE20120937A1 (es) Compuestos derivados de quinolina y quinoxalina como agentes antivirales
CR9421A (es) Compuestos heterociclicos fusionados
PE20081836A1 (es) Derivados de piperidina como inhibidores de la sintasa de acido graso
AR047056A1 (es) Derivados de pirimidinas condensadas. composiciones farmacéuticas
PE20090902A1 (es) Combinacion de un antimitotico e inhibidor de aurora quinasa como agentes anticancerigenos
PE20120666A1 (es) Inhibidores de los virus flaviviridae
AR067838A1 (es) Compuestos pirrolicos, composiciones farmaceuticas que los contienen y usos
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
ECSP045064A (es) Agonistas receptores de trombina
AR057989A1 (es) Derivados de indol-2-il-amida 1,5-sustituida. procesos de obtencion y composiciones farmaceuticas
ECSP10010060A (es) Derivados de pirazol sustituídos
PE20021092A1 (es) Antranilamidopiridinamidas selectivas como inhibidores de vegfr-2 y vegfr-3
UY28121A1 (es) Activadores de glucoquinasa heteroaromaticos de seis miembros 5-sustituidos
AR044519A1 (es) Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
MX2009006286A (es) Composiciones plaguicidas.
PE20120403A1 (es) Aril-piridinas como inhibidoras de sintasa de aldosterona
PE20070343A1 (es) Inhibidores macrociclicos del virus de la hepatitis c
PE20090709A1 (es) Compuestos heterociclico de 5 miembros
AR073932A1 (es) Compuestos de esteres de acido 2-(aminometiliden)-4,4-difluoro-3- oxobutirico y procedimiento para su preparacion
ES2297727T3 (es) Derivados de octahidropirrolo(3,4-c)pirrol y su empleo como agentes antiviricos.
PE20140968A1 (es) Derivados de benzamida sustituida
PE20040864A1 (es) Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
AR060157A1 (es) Compuestos de enamino(tio)carbonilo biciclicos, agentes que los contienen y su uso en procedimientos de lucha contra las plagas
PE20060878A1 (es) 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2

Legal Events

Date Code Title Description
FC Refusal